Iterative surgical resections in non-small cell lung cancer

dc.authoridYazgan, Serkan/0000-0001-9763-6336
dc.authoridErbaycu, Ahmet Emin/0000-0001-6618-6774
dc.authorwosidYazgan, Serkan/GSO-1911-2022
dc.authorwosidUcvet, Ahmet/B-5612-2009
dc.authorwosidErbaycu, Ahmet Emin/K-2948-2017
dc.contributor.authorÜçvet, Ahmet
dc.contributor.authorYazgan, Serkan
dc.contributor.authorSamancılar, Özgür
dc.contributor.authorGürsoy, Soner
dc.contributor.authorErbaycu, Ahmet Emin
dc.contributor.authorKömürcüoğlu, Berna
dc.date.accessioned2023-03-22T19:47:31Z
dc.date.available2023-03-22T19:47:31Z
dc.date.issued2021
dc.departmentBelirleneceken_US
dc.description.abstractIntroduction: We reviewed our surgical preferences and the prognosis for recurrent and second primary tumors in patients who underwent surgical treatment for non-small cell lung carcinoma (NSCLC). Aim: We report our experience with patients undergoing iterative pulmonary resection for lung cancer. Material and methods: Among patients who underwent anatomical resection for primary NSCLC, those who underwent a second surgical resection between 2010 and 2020 due to recurrent or second primary tumor were included in the study. Operative mortality, survival, and prognostic factors were investigated. Results: In total, 77 cases were included: 31 (40.3%) underwent the second resection for the recurrent disease and 46 (59.7%) underwent the second resection for the second primary tumor. Postoperative mortality occurred in 8 (10.4%) patients. All patients with postoperative mortality were in the group that underwent thoracotomy in both surgical procedures. The 5-year survival rate was 46.5%. The 5-year survival of those operated on for recurrent or second primary tumor was 32.8% and 51.1%, respectively (p = 0.81). The 5-year survival rate was 68.8% in patients under the age of 60 years, while it was 27.5% in patients aged 60 years and above (p = 0.004). The 5-year survival was 21.8% in patients with an interval of 36 months or less between two operations and 72.2% in those with a longer interval (p = 0.028). Conclusions: Our study shows that survival results similar to or better than primary NSCLC surgery can be obtained with lower mortality if more limited resections are performed via video-assisted thoracic surgery, especially in young patients. In addition, the prognosis is better in patients with an interval of more than 36 months between two operations.en_US
dc.identifier.doi10.5114/kitp.2021.112188
dc.identifier.endpage226en_US
dc.identifier.issn1731-5530
dc.identifier.issn1897-4252
dc.identifier.issue4en_US
dc.identifier.pmid35079263en_US
dc.identifier.scopus2-s2.0-85123360456en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage221en_US
dc.identifier.urihttps://doi.org/10.5114/kitp.2021.112188
dc.identifier.urihttps://hdl.handle.net/20.500.14034/743
dc.identifier.volume18en_US
dc.identifier.wosWOS:000742739000005en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTermedia Publishing House Ltden_US
dc.relation.journalKardiochirurgia I Torakochirurgia Polska-Polish Journal Of Thoracic And Cardiovascular Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectlung canceren_US
dc.subjectmetachronousen_US
dc.subjectsynchronousen_US
dc.subjectrecurrenceen_US
dc.subjectsurgeryen_US
dc.subjectCompletion Pneumonectomyen_US
dc.subjectFollow-Upen_US
dc.subjectMortalityen_US
dc.subjectRecurrenten_US
dc.subjectSurvivalen_US
dc.titleIterative surgical resections in non-small cell lung canceren_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
soner gürsoy.pdf
Boyut:
135.17 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin / Full text